Pooled Shrna Screening

Pooled shRNA screening is a functional genomics method that tests the effects of suppressing many genes in a cell population at the same time. Researchers introduce a library of short hairpin RNAs (shRNAs), typically using viral vectors, and each shRNA is processed into an RNA interference guide that directs the RNA-induced silencing complex to degrade or inhibit its matching messenger RNA. After applying a selection condition, such as drug treatment or nutrient stress, researchers use barcode or next-generation sequencing to identify shRNAs enriched or depleted in surviving cells. This approach reveals gene functions, pathway interactions, and potential therapeutic targets in biology and disease research.

Pooled Shrna Screening - Related Videos

Research

JoVE Journal - Biology
Free Sample

MISSION LentiPlex Pooled shRNA Library Screening in Mammalian Cells

0 Views •

Cited by 11 •

2011

Here we use a human LentiPlex pooled library and traditional sequencing methods to identify gene targets promoting cell survival. We demonstrate how to set up and deconvolute a LentiPlex screen and validate the results.

Research

JoVE Journal - Genetics

Pooled shRNA Screen for Reactivation of MeCP2 on the Inactive X Chromosome

0 Views •

Cited by 2 •

2018

We report a small hairpin RNA (shRNA) and next generation sequencing-based protocol for identifying regulators of X-chromosome inactivation in a murine cell line with firefly luciferase and hygromycin resistance genes fused to the methyl CpG binding protein 2 (MeCP2) gene on the inactive X chromosome.

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

0 Views •

Cited by 2 •

2022

High-throughput RNA interference (RNAi) screening using a pool of lentiviral shRNAs can be a tool to detect therapeutically relevant synthetic lethal targets in malignancies. We provide a pooled shRNA screening approach to investigate the epigenetic effectors in acute myeloid leukemia (AML).

Pooled CRISPR-Based Genetic Screens in Mammalian Cells

0 Views •

Cited by 14 •

2019

CRISPR-Cas9 technology provides an efficient method to precisely edit the mammalian genome in any cell type and represents a novel means to perform genome-wide genetic screens. A detailed protocol discussing the steps required for the successful performance of pooled genome-wide CRISPR-Cas9 screens is provided here.

Generating Conditional Knockdown Cells Using a Tetracycline-Responsive Lentiviral shRNA Expression System

0 Views •

2026

Source: Kubala, M. H. & DeClerck, Y. A. Conditional Knockdown of Gene Expression in Cancer Cell Lines to Study the Recruitment of Monocytes/Macrophages to the Tumor Microenvironment. J. Vis. Exp. (2017)This video demonstrates the generation of conditional knockdown cancer cell lines using a Tet-inducible lentiviral shRNA system. It outlines the steps for viral transduction, antibiotic selection, and doxycycline-induced gene silencing.

View All Results

FAQs

Related Topics